Design, synthesis and antimycobacterial evaluation of novel 3-substituted-N-aryl-6,7-dimethoxy-3a,4-dihydro-3H-indeno[1,2-c] pyrazole-2-carboxamide analogues

Bioorganic and Medicinal Chemistry Letters

Volumn 21, Issue 15, 2011, Pages 4451-4453

  Ahsan, Mohamed Jawed ^a,b   Samy, Jeyabalan Govinda ^a   Dutt, Kunduri Rajeswar ^b   Agrawal, Uttam K ^a   Yadav, Bhawani Shankar ^a   Vyas, Swati ^a   Kaur, Ravinder ^a   Yadav, Garima ^a  

^a Alwar Pharmacy College   (India)

^b NIMS UNIVERSITY   (India)

Author keywords

Antitubercular agents; Pyrazolines

Indexed keywords

N,3 BIS(4 FLUOROPHENYL) 6,7 DIMETHOXY 3A,4 DIHYDRO 3H INDENO[1,2 C]PYRAZOLE 2 CARBOXAMIDE; PYRAZOLINE DERIVATIVE; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ARTICLE; CONTROLLED STUDY; CYTOTOXICITY; DRUG DESIGN; DRUG SYNTHESIS; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN;

AMIDES; ANTITUBERCULAR AGENTS; DRUG DESIGN; DRUG RESISTANCE, BACTERIAL; INDENES; ISONIAZID; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIUM TUBERCULOSIS; PYRAZOLES;

MYCOBACTERIUM TUBERCULOSIS;

EID: 79960346729     PISSN: 0960894X     EISSN: 14643405     Source Type: Journal    
DOI: 10.1016/j.bmcl.2011.06.018     Document Type: Article

References (21)

1. A. Pablos-Mendez, M.C. Raviglione, A. Laszlo, N. Binkin, H.L. Reider, F. Bustreo, D.L. Cohn, C.S. Lambregts-van Weezenbeek, S.J. Kim, P. Chaulet, and P. Nunn N. Engl. J. Med. 338 1998 1641
2. WHO report 2010, Global Tuberculosis Control Surveillance, Financing and Planning.
3. D. Yee, C. Valiquette, M. Pelletier, I. Parison, and D. Menzies Am. J. Respir. Crit. Care Med. 167 11 2003 1472
4. L.P. Ormerod, and N. Horsifield Tuber. Lung. Dis. 77 1 1996 37
5. M.A. Ali, G.J. Samy, E. Manogaran, V. Sellappan, M.Z. Hassan, M.J. Ahsan, S. Pandian, and M. ShaharYar Bioorg. Med. Chem. Lett. 19 2009 7000
6. A. Andreani, M. Granaiola, A. Leoni, R. Morigi, and M. Ramballdi Eur. J. Med. Chem. 36 2001 743
7. S.G. Kini, A.R. Bhat, B. Bryant, J.S. Williamson, and F.E. Dayan Eur. J. Med. Chem. 44 2009 492
8. A. Budakoti, A.R. Bhat, F. Athar, and A. Azam Eur. J. Med. Chem. 43 2008 1749
9. S.S. Parmar, B.R. Pandey, C. Dwivedi, and R.D.J. Harbison Pharm. Sci. 63 1974 1152
10. B.S. Dawane, S.G. Konda, G.G. Mandawad, and B.M. Shaikh Eur. J. Med. Chem. 45 2010 387
11. P.K. Sharma, S. Kumar, P. Kumar, P. Kaushik, D. Kaushik, Y. Dhingra, and K.R. Aneja Eur. J. Med. Chem. 45 2010 2650
12. A.A. Bilgin, E. Palaska, and R. Sunal Drug Res. 43 1993 1041
13. G. Turan-Zitouni, P. Chevallet, F.S. Kili, and K. Erol Eur. J. Med. Chem. 35 2000 635
14. M.S. Mui, B.N. Siew, A.D. Buss, S.C. Crasta, L.G. Kah, and K.L. Sue Bioorg. Med. Chem. Lett. 12 2002 679
15. F. Manna, F. Chimenti, R. Fioravati, A. Bolasco, D. Secci, P. Chimenti, C. Ferlini, and G. Scambia Bioorg. Med. Chem. Lett. 15 2005 4632
16. M.A. Ali, M. Shaharyar, and A.A. Siddique Eur. J. Med. Chem. 42 2007 268
17. N. Gokhan, A. Yeilada, G. Uar, K. Erol, and A.A. Bilgin Arch. Pharm. 336 2003 362
18. S.N. Pandeya, A.S. Raja, and J.P. Stables J. Pharm Pharm. Sci. 5 3 2002 266
19. M. Amir, M.J. Ahsan, and I. Ali Ind. J. Chem. 49B 2010 1509
20. L.B. Heifets, M.A. Flory, and P.J. Lindholm-Levy Antimicrob. Agents. Chemother 33 1989 1252
21. Gundersen, L. L.; Nissen-Meyer, J.; Spilsberg, B. J. Med. Chem., 2002, 45, 1383